Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer
奥拉帕尼联合度伐利尤单抗治疗转移性去势抵抗性前列腺癌患者的II期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-014365
Li, Chennan; Madan, Ravi A; Lee, Min-Jung; Lee, Sunmin; Sato, Nahoko; Rastogi, Shraddha; Shrestha, Roshan; Aragon-Ching, Jeanny B; Goswami, Meghali; Donahue, Renee N; Cordes, Lisa M; Baj, Anna; Seo, Clara C Y; Terrigino, Nicholas T; Bright, John R; Hennigan, S Thomas; King, Isaiah M; Trostel, Shana Y; Fenimore, John M; Liu, Yi; Calzone, Kathleen A; Schlom, Jeffrey; Gulley, James L; Dahut, William L; Figg, William D; Sowalsky, Adam G; Lee, Jung-Min; Karzai, Fatima